373 related articles for article (PubMed ID: 29378619)
1. Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.
Carini C; Hunter E; ; Ramadass AS; Green J; Akoulitchev A; McInnes IB; Goodyear CS
J Transl Med; 2018 Jan; 16(1):18. PubMed ID: 29378619
[TBL] [Abstract][Full Text] [Related]
2. Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis.
Palmowski A; Strehl C; Pfeiffenberger M; Häupl T; Schad M; Kallarackal J; Prothmann U; Dammann D; Bonin M; Brandt A; Schneider U; Gaber T; Buttgereit F
Clin Rheumatol; 2024 Jan; 43(1):511-519. PubMed ID: 37978145
[TBL] [Abstract][Full Text] [Related]
3. High serum level of haptoglobin is associated with the response of 12 weeks methotrexate therapy in recent-onset rheumatoid arthritis patients.
Tan W; Wang F; Guo D; Ke Y; Shen Y; Lv C; Zhang M
Int J Rheum Dis; 2016 May; 19(5):482-9. PubMed ID: 24863583
[TBL] [Abstract][Full Text] [Related]
4. IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.
Lundström SL; Hensvold AH; Rutishauser D; Klareskog L; Ytterberg AJ; Zubarev RA; Catrina AI
Arthritis Res Ther; 2017 Aug; 19(1):182. PubMed ID: 28793911
[TBL] [Abstract][Full Text] [Related]
5. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
[TBL] [Abstract][Full Text] [Related]
6. Seropositivity-Dependent Association between LINE-1 Methylation and Response to Methotrexate Therapy in Early Rheumatoid Arthritis Patients.
Ravaei A; Pulsatelli L; Assirelli E; Meliconi R; Ciaffi J; Gremese E; Tolusso B; Salvarani C; Govoni M; Rubini M
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360249
[TBL] [Abstract][Full Text] [Related]
7. Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS).
Sergeant JC; Hyrich KL; Anderson J; Kopec-Harding K; Hope HF; Symmons DPM; ; Barton A; Verstappen SMM
Arthritis Res Ther; 2018 Jul; 20(1):147. PubMed ID: 30005689
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in Organic Anion-Transporting Polypeptide Gene Related to Methotrexate Response in Rheumatoid Arthritis Treatment.
Takahashi K; Nakamura H; Watanabe A; Majima T; Koiwa M; Kamada T; Takai S
J Nippon Med Sch; 2019; 86(3):149-158. PubMed ID: 31292326
[TBL] [Abstract][Full Text] [Related]
9. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
[TBL] [Abstract][Full Text] [Related]
10. Plasma metabolomic profiling as a tool to identify predictive biomarkers of methotrexate efficacy in rheumatoid arthritis.
Medcalf MR; Bantis LE; Shi P; Bhadbhade P; Gundry RL; Mikuls TR; England BR; O'Dell JR; Funk RS
Semin Arthritis Rheum; 2022 Oct; 56():152056. PubMed ID: 35785666
[TBL] [Abstract][Full Text] [Related]
11. Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis.
Muto S; Minamitani N; Ogura T; Nakajima A; Nakagawa K; Masaka T; Hiura S; Kobayashi H; Kato H; Kameda H
Mod Rheumatol; 2021 Nov; 31(6):1079-1086. PubMed ID: 33492182
[TBL] [Abstract][Full Text] [Related]
12. Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis.
Derambure C; Dzangue-Tchoupou G; Berard C; Vergne N; Hiron M; D'Agostino MA; Musette P; Vittecoq O; Lequerré T
Arthritis Res Ther; 2017 May; 19(1):109. PubMed ID: 28545499
[TBL] [Abstract][Full Text] [Related]
13. Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
Plant D; Maciejewski M; Smith S; Nair N; ; Hyrich K; Ziemek D; Barton A; Verstappen S
Arthritis Rheumatol; 2019 May; 71(5):678-684. PubMed ID: 30615300
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.
de Rotte MCFJ; Pluijm SMF; de Jong PHP; Bulatović Ćalasan M; Wulffraat NM; Weel AEAM; Lindemans J; Hazes JMW; de Jonge R
PLoS One; 2018; 13(12):e0208534. PubMed ID: 30532219
[TBL] [Abstract][Full Text] [Related]
15. Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis.
Singh A; Misra R; Aggarwal A
Rheumatol Int; 2019 Aug; 39(8):1431-1438. PubMed ID: 31203399
[TBL] [Abstract][Full Text] [Related]
16. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis.
Peres RS; Liew FY; Talbot J; Carregaro V; Oliveira RD; Almeida SL; França RF; Donate PB; Pinto LG; Ferreira FI; Costa DL; Demarque DP; Gouvea DR; Lopes NP; Queiroz RH; Silva JS; Figueiredo F; Alves-Filho JC; Cunha TM; Ferreira SH; Louzada-Junior P; Cunha FQ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2509-14. PubMed ID: 25675517
[TBL] [Abstract][Full Text] [Related]
17. A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
Hambardzumyan K; Saevarsdottir S; Forslind K; Petersson IF; Wallman JK; Ernestam S; Bolce RJ; van Vollenhoven RF
Arthritis Rheumatol; 2017 May; 69(5):953-963. PubMed ID: 27992691
[TBL] [Abstract][Full Text] [Related]
18. Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients.
Monserrat Sanz J; Bohórquez C; Gómez AM; Movasat A; Pérez A; Ruíz L; Diaz D; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961930
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-related Protein 8/14 Levels in Rheumatoid Arthritis: Marker of Disease Activity and Response to Methotrexate.
Patro PS; Singh A; Misra R; Aggarwal A
J Rheumatol; 2016 Apr; 43(4):731-7. PubMed ID: 26834220
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
